Background Respiratory syncytial virus (RSV) remains the leading cause of serious viral bronchiolitis and pneumonia in infants and young children throughout the world. The burden of disease is ...

Diagnostic electron microscopy is a valuable tool for supporting diagnosis and research of pathogenesis of infectious diseases. To advance the application and the development of deep learning in virus ...

Respiratory syncytial virus (RSV) infections can lead to serious complications, particularly in infants and older adults aged 75 years and above. Recent advancements in vaccine trials for older ...

New data for AREXVY, GSK’s RSV vaccine, show potential to help protect a broader group of adults at increased risk for RSV disease ...

GSK presents positive data for AREXVY, its respiratory syncytial virus (RSV) vaccine, indicating protection over three RSV seasons ...

New images of RSV may expose stubborn virus's weak points Date: October 1, 2024 Source: University of Wisconsin-Madison Summary: The complex shape of respiratory syncytial virus is one hurdle ...

Learn about Respiratory Syncytial Virus (RSV), its symptoms, treatment, and prevention. Get expert advice on how to protect vulnerable populations from this viral infection.

More information: Eeva K Broberg et al, Respiratory syncytial virus infections—recent developments providing promising new tools for disease prevention, Eurosurveillance (2023).

Despite binding to respiratory syncytial virus particles, platelets do not undergo activation or degranulation, suggesting they do not contribute directly to the immune response causing severe RSV ...

Respiratory syncytial virus (RSV) is an important cause of acute respiratory infection, lower respiratory tract disease, clinical complications, and death in older adults. There is currently no lic ...

A: Respiratory syncytial virus is a seasonal respiratory virus that usually causes mild, cold-like symptoms. Most people recover in a week or two, but RSV can be serious, especially for infants and ...